A Study to Investigate the Interaction Between TMP-301 and Cocaine.
- First Posted Date
- 2024-10-18
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Tempero Bio, Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT06648668
- Locations
- 🇺🇸
Dr. Vince Clinical Research, Overland Park, Kansas, United States
A Study to Investigate the Safety and Efficacy of TMP-301 Compared to Placebo in Adult Patients With Alcohol Use Disorder
- First Posted Date
- 2024-10-18
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- Tempero Bio, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT06648655
- Locations
- 🇺🇸
CNS Healthcare- Jacksonville South, Jacksonville, Florida, United States
🇺🇸University of Virginia: Center for Leading Edge Addiction Research, Charlottesville, Virginia, United States
🇺🇸Headlands Research, Scottsdale, Arizona, United States
Multiple Ascending Dose Study of TMP-301 in Healthy Subjects
Phase 1
Completed
- Conditions
- Cocaine Use DisorderSubstance Use DisordersHealthy Volunteers
- Interventions
- Drug: Placebo
- First Posted Date
- 2023-09-06
- Last Posted Date
- 2024-01-17
- Lead Sponsor
- Tempero Bio, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT06025396
- Locations
- 🇺🇸
Altasciences, Overland Park, Kansas, United States
© Copyright 2025. All Rights Reserved by MedPath